Efgartigimod as Fast-Acting Rescue Therapy in Very Late-Onset Myasthenia Gravis
Abstract Myasthenic crisis (MC) is a potentially fatal complication of myasthenia gravis (MG), often requiring intensive care and rescue therapies such as intravenous immunoglobulin (IVIG) and corticosteroids. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, offers a novel approach by selecti...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Adis, Springer Healthcare
2025-11-01
|
| Serier: | Neurology and Therapy |
| Fag: | |
| Online adgang: | https://doi.org/10.1007/s40120-025-00857-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
